Antineutrophil cytoplasmic antibody-associated vasculitis and VEXAS syndrome: comment on the article by Muratore et al.
作者信息
Koster Matthew J, Ghaffar Umar, Kermani Tanaz A, Patnaik Mrinal M, Go Ronald S, Mangaonkar Abhishek A, Reichard Kaaren K, Olteanu Horatiu, Warrington Kenneth J
机构信息
Division of Rheumatology, Department of Internal Medicine, Mayo Clinic, Rochester, MN.
Division of Rheumatology, Department of Internal Medicine, University of California, Los Angeles, Santa Monica, CA.
出版信息
Arthritis Rheumatol. 2023 Aug;75(8):1490-1492. doi: 10.1002/art.42466. Epub 2023 May 17.
PMID:36716119
Abstract
摘要
相似文献
1
Antineutrophil cytoplasmic antibody-associated vasculitis and VEXAS syndrome: comment on the article by Muratore et al.抗中性粒细胞胞浆抗体相关性血管炎与VEXAS综合征：对穆拉托雷等人文章的评论
Arthritis Rheumatol. 2023 Aug;75(8):1490-1492. doi: 10.1002/art.42466. Epub 2023 May 17.
2
Intravenous Immunoglobulin in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Comment on the Article by Crickx et al.静脉注射免疫球蛋白治疗抗中性粒细胞胞浆抗体相关性血管炎：对Crickx等人文章的评论
Arthritis Rheumatol. 2016 Dec;68(12):3045-3046. doi: 10.1002/art.39858.
3
Power and Confounding in Diffuse Alveolar Hemorrhage Secondary to Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Comment on the Article by Cartin-Ceba et al.抗中性粒细胞胞浆抗体相关血管炎继发弥漫性肺泡出血中的检验效能与混杂因素：对卡廷 - 塞瓦等人文章的评论
Arthritis Rheumatol. 2016 Nov;68(11):2827-2828. doi: 10.1002/art.39826.
4
How can we predict the risk of relapse in antineutrophil cytoplasmic antibody-associated vasculitis? Comment on the article by Walsh et al.我们如何预测抗中性粒细胞胞浆抗体相关性血管炎的复发风险？评沃尔什等人的文章
Arthritis Rheum. 2012 Sep;64(9):3057-8; author reply 3058. doi: 10.1002/art.34590.
5
Assessing Cardiovascular Risk in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Comment on the Article by Wallace et al.评估抗中性粒细胞胞浆抗体相关性血管炎患者的心血管风险：对Wallace等人文章的评论
Arthritis Rheumatol. 2020 Jan;72(1):200-201. doi: 10.1002/art.41080. Epub 2019 Nov 21.
6
Panniculitis As the First Clinical Manifestation of Myeloperoxidase-Positive Perinuclear Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Comment on the Article by Micheletti et al.脂膜炎作为髓过氧化物酶阳性核周型抗中性粒细胞胞浆抗体相关血管炎的首发临床表现：对Micheletti等人文章的评论
Arthritis Rheumatol. 2021 Jun;73(6):1088-1089. doi: 10.1002/art.41662. Epub 2021 Apr 2.
7
Rituximab versus cyclophosphamide for remission induction in active, severe antineutrophil cytoplasmic antibody-associated vasculitis: comment on the article by Chung et al.利妥昔单抗与环磷酰胺用于诱导活动性重症抗中性粒细胞胞浆抗体相关性血管炎缓解：对Chung等人文章的评论
Arthritis Rheumatol. 2022 Mar;74(3):544-545. doi: 10.1002/art.42002. Epub 2022 Jan 18.
8
Rituximab for Antineutrophil Cytoplasmic Antibody-Associated Vasculitis-Not Everything in the Garden Is Rosy: Comment on the Article by Cortazar et al.利妥昔单抗治疗抗中性粒细胞胞浆抗体相关性血管炎——并非一切都美好：对科塔萨尔等人文章的评论
Arthritis Rheumatol. 2017 Oct;69(10):2094-2095. doi: 10.1002/art.40209. Epub 2017 Aug 22.
9
Antineutrophil cytoplasmic autoantibodies: an unbiased and efficient tool to classify renal vasculitis? Comment on the article by Lionaki et al.抗中性粒细胞胞浆自身抗体：一种用于对肾血管炎进行分类的客观且有效的工具？对Lionaki等人文章的评论
Arthritis Rheum. 2013 May;65(5):1405-6. doi: 10.1002/art.37892.
10
Recognition of Rare, Atypical Manifestations Is Important for Diagnosis and Management of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Comment on the Article by Delaval et al.认识罕见、非典型表现对抗中性粒细胞胞浆抗体相关血管炎的诊断和管理很重要：对Delaval等人文章的评论
Arthritis Rheumatol. 2021 Apr;73(4):719. doi: 10.1002/art.41590. Epub 2021 Feb 18.
引用本文的文献
1
Kidney involvement in VEXAS syndrome: insights from a rare case of secondary amyloidosis and systematic review of renal biopsy-confirmed reports.VEXAS综合征中的肾脏受累：一例罕见的继发性淀粉样变性病例及肾活检确诊报告的系统评价启示
Clin Rheumatol. 2025 Jul;44(7):3101-3108. doi: 10.1007/s10067-025-07506-9. Epub 2025 May 30.
2
VEXAS Syndrome-Diagnostic Clues for the Dermatologist and Gaps in Our Current Understanding: A Narrative Review.VEXAS综合征——皮肤科医生的诊断线索及我们当前认知的差距：一篇叙述性综述
JID Innov. 2023 Oct 29;4(1):100242. doi: 10.1016/j.xjidi.2023.100242. eCollection 2024 Jan.
Zotero 插件